Jessica Sachs

Insider Reports History

Entity
Individual
Location
C/O Unum Therapeutics Inc., 200 Cambridge Park Drive, Cambridge, MA
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jessica Sachs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cogent Biosciences, Inc. Chief Medical Officer Stock Option (Right to Buy) 300K $2.16M $7.19 Jan 23, 2024 Direct

Insider Reports Filed by Jessica Sachs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COGT Cogent Biosciences, Inc. Jan 23, 2024 1 $0 4 Jan 25, 2024 Chief Medical Officer
COGT Cogent Biosciences, Inc. Feb 13, 2023 1 $0 4 Feb 15, 2023 Chief Medical Officer
COGT Cogent Biosciences, Inc. Jun 30, 2022 1 $4.6K 4 Jul 1, 2022 Chief Medical Officer
COGT Cogent Biosciences, Inc. Jan 25, 2022 1 $1.24M 4 Jan 27, 2022 Chief Medical Officer
COGT Cogent Biosciences, Inc. Dec 31, 2021 1 $4.59K 4 Jan 4, 2022 Chief Medical Officer